Predicted protein targets (top 2)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTSA | P10619 | 17/20 | 0.57 |
| ▸ | CYP26A1 | O43174 | 3/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16223720 | 1.00 | CTSA (0.57) | CTSACYP26A1 | |
| SCHEMBL15636917 | 0.91 | CTSA (0.55) | CTSACYP26A1 | |
| SCHEMBL15636249 | 0.91 | CYP26A1 (0.53) | CTSACYP26A1 | |
| SCHEMBL15636745 | 0.91 | CYP26A1 (0.53) | CTSACYP26A1 | |
| SCHEMBL15635936 | 0.90 | CTSA (0.47) | CTSACYP26A1 | |
| SCHEMBL15636445 | 0.90 | CTSA (0.60) | CTSACYP26A1 | |
| SCHEMBL15635967 | 0.90 | CTSA (0.53) | CTSACYP26A1 | |
| SCHEMBL15636694 | 0.90 | CTSA (0.57) | CTSACYP26A1 | |
| SCHEMBL15635977 | 0.90 | CTSA (0.57) | CTSACYP26A1 | |
| SCHEMBL15636099 | 0.89 | CTSA (0.55) | CTSACYP26A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2826772-A1 | Intermediates for the synthesis of oxygen-substituted 3-heteroaroylamino-propionic acid derivatives | SANOFI (FR) | 2015-01-21 | — | — | EP | disclosed |
| EP-2528902-B1 | OXYGEN-SUBSTITUTED 3-HETEROAROYLAMINO-PROPIONIC ACID DERIVATIVES AND THEIR USE AS PHARMACEUTICALS | SANOFI SA (FR) | 2014-11-12 | — | — | EP | disclosed |
| WO-2014053533-A1 | USE OF SUBSTITUTED 3-HETEROAROYLAMINO-PROPIONIC ACID DERIVATIVES AS PHARMACEUTICALS FOR PREVENTION/TREATMENT OF ATRIAL FIBRILLATION | SANOFI (FR) | 2014-04-10 | — | — | WO | disclosed |